Top Markets
Coin of the day
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
Rang in aandelen #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
Aandeelprijs
$0.09933121
Marktkapitalisatie
$29.15K
Verandering (1 dag)
0.57%
Verandering (1 jaar)
449.49%
Land
IE
Handel Ovoca Bio plc (OVB)

Categorie

Winst voor Ovoca Bio plc (OVB)
Winst in Jun 2024 TTM: $-5.54M
Volgens de meest recente financiële verslagen van Ovoca Bio plc bedraagt de huidige winst van het bedrijf $-5.54M. In 2023 behaalde het bedrijf een winst van $-5.64M, een stijging ten opzichte van de winst van 2022, die $-6.02M bedroeg. De weergegeven winst op deze pagina is de winst vóór rente en belastingen, oftewel EBIT.
Winstgeschiedenis van Ovoca Bio plc van 2001 tot 2026
Winst aan het einde van elk jaar
Jaar Winst Wijzigen
2026 (TTM) $-5.54M 177,402.36%
2024 $-3.12K -99.94%
2023 $-5.64M -6.27%
2022 $-6.02M 0.89%
2021 $-5.97M 111.35%
2020 $-2.82M 32.29%
2019 $-2.13M -6.96%
2018 $-2.29M 401.73%
2017 $-457.16K -54.69%
2016 $-1.01M -58.18%
2015 $-2.41M -69.99%
2014 $-8.04M -60.54%
2013 $-20.37M 592.33%
2012 $-2.94M -153.33%
2011 $5.52M 340.98%
2010 $1.25M -87.44%
2009 $9.96M -683.08%
2008 $-1.71M 36.71%
2007 $-1.25M -81.83%
2006 $-6.88M 549.04%
2005 $-1.06M 285.00%
2004 $-275.29K 10.93%
2003 $-248.17K 96.02%
2002 $-126.60K -32.76%
2001 $-188.29K 0.00%
Winst van vergelijkbare bedrijven of concurrenten
Bedrijf Winst Winstverschil Land
$20.46B -369,289.88%
DK
$4.64B -83,895.77%
US
$5.23B -94,498.38%
US
$2.14B -38,678.95%
BE
$1.45B -26,287.63%
NL